Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

E-ISSN： 1096-8652|90|12|E219-E220

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.12, 2015-12, pp. : E219-E220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1058-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 992-997

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytogenetically Normal Acute Myeloid Leukemia with a Novel KIT Mutation in Exon 11 G565V Developing a Sole Trisomy 13 at Relapse: A Clinical Dilemma

Acta Haematologica, Vol. 133, Iss. 1, 2014-06 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Multidrug Resistance as a Potential Prognostic Indicator in Acute Myeloid Leukemia with Normal Karyotypes

Acta Haematologica, Vol. 114, Iss. 2, 2005-08 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

CANCER, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

John Wiley & Sons Inc

Access to resources Recommend Favorite